OBJECTIVE: Chronic pancreatitis, characterized by pancreatic exocrine tissue destruction with initial maintenance of islets, eventually leads to insulin-dependent diabetes in most patients. Mice deficient for the transcription factors E2F1 and E2F2 suffer from a chronic pancreatitis-like syndrome and become diabetic. Surprisingly, onset of diabetes can be prevented through bone marrow transplantation. The goal of the described studies was to determine the hematopoietic cell type responsible for maintaining islets and the associated mechanism of this protection. RESEARCH DESIGN AND METHODS: Mouse models of acute and chronic pancreatitis, together with mice genetically deficient for macrophage production, were used to determine roles for macrophages in islet angiogenesis and maintenance. RESULTS: We demonstrate that macrophages are essential for preventing endocrine cell loss and diabetes. Macrophages expressing matrix metalloproteinase-9 migrate to the deteriorating pancreas. E2f1/E2f2 mutant mice transplanted with wild-type, but not macrophage-deficient colony stimulating factor 1 receptor mutant (Csf1r(-/-)), bone marrow exhibit increased angiogenesis and proliferation within islets, coinciding with increased islet mass. A similar macrophage dependency for islet and islet vasculature maintenance is observed during caerulein-induced pancreatitis. CONCLUSIONS: These findings demonstrate that macrophages promote islet angiogenesis and protect against islet loss during exocrine degeneration, could explain why most patients with chronic pancreatitis develop diabetes, and suggest an avenue for preventing pancreatitis-associated diabetes.
OBJECTIVE:Chronic pancreatitis, characterized by pancreatic exocrine tissue destruction with initial maintenance of islets, eventually leads to insulin-dependent diabetes in most patients. Mice deficient for the transcription factors E2F1 and E2F2 suffer from a chronic pancreatitis-like syndrome and become diabetic. Surprisingly, onset of diabetes can be prevented through bone marrow transplantation. The goal of the described studies was to determine the hematopoietic cell type responsible for maintaining islets and the associated mechanism of this protection. RESEARCH DESIGN AND METHODS: Mouse models of acute and chronic pancreatitis, together with mice genetically deficient for macrophage production, were used to determine roles for macrophages in islet angiogenesis and maintenance. RESULTS: We demonstrate that macrophages are essential for preventing endocrine cell loss and diabetes. Macrophages expressing matrix metalloproteinase-9 migrate to the deteriorating pancreas. E2f1/E2f2 mutant mice transplanted with wild-type, but not macrophage-deficient colony stimulating factor 1 receptor mutant (Csf1r(-/-)), bone marrow exhibit increased angiogenesis and proliferation within islets, coinciding with increased islet mass. A similar macrophage dependency for islet and islet vasculature maintenance is observed during caerulein-induced pancreatitis. CONCLUSIONS: These findings demonstrate that macrophages promote islet angiogenesis and protect against islet loss during exocrine degeneration, could explain why most patients with chronic pancreatitis develop diabetes, and suggest an avenue for preventing pancreatitis-associated diabetes.
Authors: Giovanna Gallina; Luigi Dolcetti; Paolo Serafini; Carmela De Santo; Ilaria Marigo; Mario P Colombo; Giuseppe Basso; Frank Brombacher; Ivan Borrello; Paola Zanovello; Silvio Bicciato; Vincenzo Bronte Journal: J Clin Invest Date: 2006-10 Impact factor: 14.808
Authors: Marcela Brissova; Alena Shostak; Masakazu Shiota; Peter O Wiebe; Greg Poffenberger; Jeannelle Kantz; Zhongyi Chen; Chad Carr; W Gray Jerome; Jin Chen; H Scott Baldwin; Wendell Nicholson; David M Bader; Thomas Jetton; Maureen Gannon; Alvin C Powers Journal: Diabetes Date: 2006-11 Impact factor: 9.461
Authors: Ksenya Shchors; Elena Shchors; Fanya Rostker; Elizabeth R Lawlor; Lamorna Brown-Swigart; Gerard I Evan Journal: Genes Dev Date: 2006-09-15 Impact factor: 11.361
Authors: Joao Incio; Josh Tam; Nuh N Rahbari; Priya Suboj; Dan T McManus; Shan M Chin; Trupti D Vardam; Ana Batista; Suboj Babykutty; Keehoon Jung; Anna Khachatryan; Tai Hato; Jennifer A Ligibel; Ian E Krop; Stefan B Puchner; Christopher L Schlett; Udo Hoffmman; Marek Ancukiewicz; Masabumi Shibuya; Peter Carmeliet; Raquel Soares; Dan G Duda; Rakesh K Jain; Dai Fukumura Journal: Clin Cancer Res Date: 2016-02-09 Impact factor: 12.531
Authors: Naomi Van Gassen; Willem Staels; Eva Van Overmeire; Sofie De Groef; Mozhdeh Sojoodi; Yves Heremans; Gunter Leuckx; Mark Van de Casteele; Jo A Van Ginderachter; Harry Heimberg; Nico De Leu Journal: Stem Cells Transl Med Date: 2015-04-06 Impact factor: 6.940
Authors: Fong Cheng Pan; Eric D Bankaitis; Daniel Boyer; Xiaobo Xu; Mark Van de Casteele; Mark A Magnuson; Harry Heimberg; Christopher V E Wright Journal: Development Date: 2013-01-16 Impact factor: 6.868